miR-30e-5p调控口腔鳞癌细胞增殖和迁移的实验研究

doi:10.3969/j.issn.1005-4979.2018.03.003

摘要/Abstract

摘要： 目的：研究miR-30e-5p对口腔鳞癌细胞增殖和迁移能力的影响，探讨其在口腔鳞癌发生发展中的作用。方法：实时荧光定量PCR检测miR-30e-5p在人口腔鳞癌组织、癌旁组织、正常口腔黏膜上皮细胞和HN6细胞系中的表达水平。应用miR-30e-5p mimics、miR-30e-5p inhibitor、mimics NC、inhibitor NC分别转染HN6细胞，实时荧光定量PCR检测转染后miR-30e-5p的表达变化；采用细胞增殖实验、平板克隆形成实验、划痕实验分别检测miR-30e-5p对HN6细胞生长和迁移的影响。结果：相对于癌旁正常组织，miR-30e-5p在口腔鳞癌组织中的表达显著下调（P<0.05）。相对于正常口腔黏膜上皮细胞，miR-30e-5p在口腔鳞癌组织中的表达显著下调（P<0.05）。转染miR-30e-5p mimics后，HN6细胞的增殖能力、克隆形成能力及迁移能力显著降低，而转染miR-30e-5p inhibitor后，HN6细胞的增殖能力、克隆形成能力及迁移能力则明显升高，差异均具有统计学意义（P<0.05）。结论：miR-30e-5p在口腔鳞癌组织中低表达，与口腔鳞癌细胞的生长和迁移密切相关，提示miR-30e-5p在口腔鳞癌的发生、发展过程中可能起抑癌基因的作用。

关键词: miR-30e-5p, 口腔鳞癌, 增殖, 迁移

Abstract: Objective: The aim of this study was to investigate the effects of miR-30e-5p on the proliferation and migration of tumor cells in oral squamous cell carcinoma (OSCC), and to determine its role in OSCC progression. Methods: The expressions of miR-30e-5p in OSCC tissues, adjacent normal tissues, normal oral mucosal epithelial cells and HN6 cells were individually examined by real-time quantitative PCR. The miR-30e-5p mimics, miR-30e-5p inhibitor, mimics NC and inhibitor NC were transfected into HN6 cells, respectively. Transfection efficiency and expression level of miR-30e-5p were detected by quantitative real-time PCR assay. The proliferation assay, plate colony formation assay and wound healing assay were performed to study the effects of miR-30e-5p on cell proliferation and migration. Results: The expressions of miR-30e-5p was down-regulated in OSCC tissues when compared with the paired normal tissues (P<0.05). Similarly, the expressions of miR-30e-5p was down-regulated in HN6 cells when compared with the normal oral mucosal epithelial cells (P<0.05). Overexpression of miR-30e-5p in HN6 cells significantly inhibited the proliferation, colony formation and migration abilities of HN6 cells (P<0.05); while silencing of miR-30e-5p by miR-30e-5p inhibitor in HN6 cells remarkably promote the proliferation, colony formation and migration abilities of HN6 cells (P<0.05). Conclusions: miR-30e-5p was down-regulated in OSCC and the expression of miR-30e-5p was correlated with the proliferation and migration of tumor cells, which indicated that miR-30e-5p may play a vital role as tumor suppressor gene during the development and progression of OSCC.

Key words: miR-30e-5p, oral squamous cell carcinoma, proliferation, migration

中图分类号:

R782.4

朱雪琴，叶冬霞，秦星，陈万涛. miR-30e-5p调控口腔鳞癌细胞增殖和迁移的实验研究[J]. 《口腔颌面外科杂志》, doi: 10.3969/j.issn.1005-4979.2018.03.003.

ZHU Xue-qin, YE Dong-xia, QIN Xing, CHEN Wan-tao. miR-30e-5p Regulates Proliferation and Migration of Oral Squamous Cell Carcinoma[J]. 《Journal of Oral and Maxillofacial Surgery》, doi: 10.3969/j.issn.1005-4979.2018.03.003.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2018/V28/I3/135

参考文献

[1] Ng JH, Iyer NG, Tan MH, et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study[J]. Head Neck, 2017, 39(2):297-304.

[2] Shield KD, Ferlay J, Jemal A, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012[J]. CA Cancer J Clin, 2017, 67(1):51-64.

[3] Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma--an update[J]. CA Cancer J Clin, 2015, 65(5):401-421.

[4] Ambros V. MicroRNA pathways in flies and Worms: growth, death, fat, stress, and timing[J]. Cell, 2003, 113(6):673-676.[PubMed]

[5] Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2):281-297.

[6] Rupaimoole R, Calin GA, Lopez-Berestein G, et al. MiRNA deregulation in cancer cells and the tumor microenvironment[J]. Cancer Discov, 2016, 6(3):235-246.

[7] Karatas OF, Oner M, Abay A, et al. MicroRNAs in human tongue squamous cell carcinoma: From pathogenesis to therapeutic implications[J]. Oral Oncol, 2017, 67:124-130.

[8] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.

[9] Ernani V, Saba NF. Oral cavity cancer: risk factors, pathology, and management[J]. Oncology, 2015, 89(4):187-195.

[10] Amit M, Yen TC, Liao CT, et al. Improvement in survival of patients with oral cavity squamous cell carcinoma: An international collaborative study[J]. Cancer, 2013, 119(24):4242-4248.

[11] Krishnan K, Steptoe AL, Martin HC, et al. MicroRNA-182-5p targets a network of genes involved in DNA repair[J]. RNA, 2013, 19(2):230-242.

[12] Bu WJ, Luo TY. Mir-1297 promotes cell proliferation of non-small cell lung cancer cells: involving in PTEN/Akt/Skp2 signaling pathway[J]. DNA Cell Biol, 2017, 36(11):976-982.

[13] Wang YN, Xue JF, Kuang HY, et al. MicroRNA-1297 inhibits the growth and metastasis of colorectal cancer by suppressing cyclin D2 expression[J]. DNA Cell Biol, 2017, 36(11): 991-999.

[14] Kumarswamy R, Mudduluru G, Ceppi P, et al. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer[J]. Int J Cancer, 2012, 130(9):2044-2053.

[15] Liu ZY, Tu KS, Liu QG. Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma[J]. FEBS Lett, 2014, 588(17):3089-3097.

[16] Sousa JF, Nam KT, Petersen CP, et al. MiR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach[J]. Gut, 2016, 65(6):914-924.

[17] Wang G, Zhang H, He H, et al. Up-regulation of microRNA in bladder tumor tissue is not common[J]. Int Urol Nephrol, 2010, 42(1):95-102.

[18] Lin ZY, Li JW, Wang YH, et al. Abnormal miRNA-30e expression is associated with breast cancer progression[J]. Clin Lab, 2016, 62(1-2): 121-128.

[19] John B, Enright AJ, Aravin A, et al. Human MicroRNA targets[J]. PLoS Biol, 2004, 2(11):e363.

[20] Ambros V. The functions of animal microRNAs[J]. Nature, 2004, 431(7006):350-355.

[21] Yu P, Liu K, Gao XX, et al. Transforming growth factor-β and bone morphogenetic protein 2 regulation of MicroRNA-200 family in chronic pancreatitis[J]. Pancreas, 2018, 47(2):252-256.

[22] Urbas R, Mayr C, Klieser E, et al. Relevance of MicroRNA200 family and MicroRNA205 for epithelial to mesenchymal transition and clinical outcome in biliary tract cancer patients[J]. Int J Mol Sci, 2016, 17(12):E2053.

[23] Bracken CP, Li XC, Wright JA, et al. Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion[J]. EMBO J, 2014, 33(18):2040-2056.

[24] Wang CL, Cai LC, Liu J, et al. MicroRNA-30a-5p inhibits the growth of renal cell carcinoma by modulating GRP78 expression[J]. Cell Physiol Biochem, 2017, 43(6):2405-2419.

[25] Fu J, Xu XJ, Kang L, et al. MiR-30a suppresses breast cancer cell proliferation and migration by targeting Eya2[J]. Biochem Biophys Res Commun, 2014, 445(2):314-319.

[26] Bockhorn J, Dalton R, Nwachukwu C, et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11[J]. Nat Commun, 2013, 4:1393.

[27] Zhang N, Wang X, Huo Q, et al. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin[J]. Oncogene, 2014, 33(24):3119-3128.

[28] Shi X, Wang X. The role of MTDH/AEG-1 in the progression of cancer[J]. Int J Clin Exp Med, 2015, 8(4): 4795-4807.

[29] Ouzounova M, Vuong T, Ancey PB, et al. MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells[J]. BMC Genomics, 2013, 14:139.

[30] Bockhorn J, Yee K, Chang YF, et al. MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion[J]. Breast Cancer Res Treat, 2013, 137(2):373-382.

[31] Cinpolat O, Unal ZN, Ismi O, et al. Comparison of microRNA profiles between benign and malignant salivary gland tumors in tissue, blood and saliva samples: a prospective, case-control study[J]. Braz J Otorhinolaryngol, 2017, 83(3):276-284.

[32] Chaw SY, Abdul Majeed A, Dalley AJ, et al. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation[J]. Oral Oncol, 2012, 48(10):997-1006.

[33] Nagao T, Sato E, Inoue R, et al. Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice[J]. Acta Histochem Cytochem, 2012, 45(5):269-282.

选择文件类型/文献管理软件名称

选择包含的内容